September, 01 2024 Sunday 08:40 Hrs
  • SENSEX :   82,365.77

  • Commodity broking firm in India231.16( 0.28%) 30-Aug-2024
top-arrow-market
Sensex 82365.77 231.16  (0.28) 30-Aug-2024
Previous Day Close
82134.61
Today's High/Low
High Low
  •  
  •  
82637.03 82256.02

Company News Details

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
507.93558
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
81.4
135213.77
EPS(TTM)
Face Value()
Div & Yield %
62.57
2
0.59
 

Divis Laboratories Ltd
Divi's Laboratories consolidated net profit rises 20.79% in the June 2024 quarter
Aug 03,2024
Net profit of Divi's Laboratories rose 20.79% to Rs 430.00 crore in the quarter ended June 2024 as against Rs 356.00 crore during the previous quarter ended June 2023. Sales rose 19.12% to Rs 2118.00 crore in the quarter ended June 2024 as against Rs 1778.00 crore during the previous quarter ended June 2023.

ParticularsQuarter Ended
Jun. 2024Jun. 2023% Var.
Sales2118.001778.00 19
OPM %29.3728.35 -
PBDT701.00585.00 20
PBT604.00492.00 23
NP430.00356.00 21
Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.